Keywords: antigenics, acquire, aronex, pharmaceuticals, briefly, mentioned, last
Antigenics to acquire Aronex Pharmaceuticals
Article | 27 April 2001
As briefly mentioned in last week's Marketletter, Antigenics has signeda definitive agreement to acquire Aronex Pharmaceuticals in a stock-for-stock transaction. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
